Srivatsa Shachi, Al-Hadidi Ameer, Stanek Joseph, Horvath Kyle, Parsons Lauren, Martinez-Rios Claudia, Hopp Amanda, Engle Samuel, Plunk Matthew, Shapira-Zaltsberg Gali, Nagar Sapna, Masters Sean, Al-Katib Sayf, Tucker Rennard, Atweh Lamya A, Shah Summit, Bobbey Adam, Hoffman Robert, Aldrink Jennifer H
Center for Surgical Outcomes Research, Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, OH, USA.
Nationwide Children's Hospital Research Institute, Nationwide Children's Hospital, Columbus, OH, USA.
J Pediatr Surg. 2025 Jan;60(1):161924. doi: 10.1016/j.jpedsurg.2024.161924. Epub 2024 Sep 13.
Thyroid nodules are uncommon in children and adolescents but carry an increased risk of malignancy when present. The Thyroid Imaging Reporting and Data System (TI-RADS) is an adult-validated ultrasound-based risk assessment providing a prediction of malignant potential for thyroid nodules, thereby guiding recommendations for fine needle aspiration biopsy (FNAB). Minimal data exist regarding the applicability of TI-RADS to predict malignancy in pediatric thyroid nodules. This study aims to analyze the performance of TI-RADS for children and adolescents with thyroid nodules, hypothesizing that applying TI-RADS criteria would improve accuracy and reduce the number of recommended FNAB compared to American Thyroid Association (ATA) size criteria alone.
A multi-institutional retrospective analysis was conducted including patients ≤21 years with a thyroid nodule by sonographic thyroid imaging between 2015 and 2020. TI-RADS scores were assigned at each institution by a pediatric radiologist trained in thyroid imaging and TI-RADS criteria. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and overall accuracy of TI-RADS scoring were compared to existing ATA size-based recommendation for performing a FNAB. Accounting for relative size differences between adults and children, a novel PED TI-RADS category was developed and tested, recommending FNAB for thyroid nodules with a TI-RADS 3 and ≥ 1.5 cm, TI-RADS 4 and ≥ 1.0 cm, and TI-RADS 5 any feasible size.
291 nodules from 260 patients (median age 14.9 years, 78.8% female) were assessed using TI-RADS. Applying adult TI-RADS criteria resulted in recommendation of FNAB for 35.1% of nodules, in contrast to 76.6% recommended by ATA guidelines (p < 0.0001) (Table). Utilizing the adult TI-RADS score ≥3 as an FNAB indicator resulted in 100% sensitivity and 28.5% specificity, with 0 cases of missed malignant nodules on pathology. When novel PED TI-RADS criteria were applied, 88 patients would have been spared an unnecessary FNAB with improved sensitivity and accuracy over ATA criteria.
The application of adult and PED TI-RADS scoring to thyroid nodules in pediatric patients enhances the accuracy of malignancy prediction compared to current American Thyroid Association size criteria alone. The utilization of PED TI-RADS scoring eliminated unnecessary biopsies in many children while not missing a single thyroid malignancy.
Level III.
甲状腺结节在儿童和青少年中并不常见,但一旦出现,其恶性风险会增加。甲状腺影像报告和数据系统(TI-RADS)是一种基于超声的、经成人验证的风险评估方法,可预测甲状腺结节的恶性潜能,从而指导细针穿刺活检(FNAB)的建议。关于TI-RADS在预测儿童甲状腺结节恶性方面的适用性数据极少。本研究旨在分析TI-RADS在儿童和青少年甲状腺结节中的表现,假设应用TI-RADS标准与仅采用美国甲状腺协会(ATA)大小标准相比,将提高准确性并减少推荐的FNAB数量。
进行了一项多机构回顾性分析,纳入了2015年至2020年间通过超声甲状腺成像发现甲状腺结节的21岁及以下患者。每个机构由接受过甲状腺成像和TI-RADS标准培训的儿科放射科医生分配TI-RADS评分。将TI-RADS评分的敏感性、特异性、阳性预测值(PPV)、阴性预测值(NPV)和总体准确性与现有的基于ATA大小的FNAB执行建议进行比较。考虑到成人和儿童之间的相对大小差异,开发并测试了一种新的PED TI-RADS类别,建议对TI-RADS 3且≥1.5 cm、TI-RADS 4且≥1.0 cm以及TI-RADS 5(任何可行大小)的甲状腺结节进行FNAB。
使用TI-RADS评估了260例患者(中位年龄14.9岁,78.8%为女性)的291个结节。应用成人TI-RADS标准导致35.1%的结节被建议进行FNAB,相比之下,ATA指南建议的比例为76.6%(p < 0.0001)(表)。将成人TI-RADS评分≥3作为FNAB指标,敏感性为100%,特异性为28.5%,病理检查未发现漏诊的恶性结节。应用新的PED TI-RADS标准时,88名患者可避免不必要的FNAB,与ATA标准相比,敏感性和准确性有所提高。
与目前仅采用美国甲状腺协会大小标准相比,将成人和PED TI-RADS评分应用于儿科患者的甲状腺结节可提高恶性预测的准确性。使用PED TI-RADS评分消除了许多儿童不必要的活检,同时没有漏诊任何一例甲状腺恶性肿瘤。
三级。